# Modified transport medium for improving influenza virus detection

**Authors:** Zhiqi Zeng, Qianying Li, Hua Guo, Yong Liu, Lixi Liang, Yuanfang Lai, Yi Fang, Lei Li, Qiuting Xue, Yangqing Zhan, Zhengshi Lin, Wenda Guan, Zifeng Yang

PMC · DOI: 10.3389/fcimb.2024.1399782 · Frontiers in Cellular and Infection Microbiology · 2024-07-04

## TL;DR

A modified transport medium improves influenza virus detection in clinical samples by increasing viral load and detection sensitivity.

## Contribution

A novel transport medium was developed that significantly enhances influenza virus detection sensitivity in clinical samples.

## Key findings

- MTM increased detection sensitivity for H1N1, H9N2, and IBVs by 10-fold, H3N2 by 100-fold, and H7N3 by 1,000-fold.
- MTM improved the positive detection rate of IAV clinical samples from 63.16% to 89.47% after 72 hours of culturing.
- MTM outperformed other transport mediums in viral detection rate by 11.81% (P=0.007).

## Abstract

Accurate detection of influenza virus in clinical samples requires correct execution of all aspects of the detection test. If the viral load in a sample is below the detection limit, a false negative result may be obtained. To overcome this issue, we developed a modified transport medium (MTM) for clinical sample transportation to increase viral detection sensitivity.

We first validated the MTM using laboratory-stocked influenza A viruses (IAVs: H1N1, H3N2, H7N3, H9N2) and influenza B viruses (IBVs: Yamagata, Victoria). We also tested clinical samples. A total of 110 patients were enrolled and a pair of samples were collected to determine the sensitivity of real-time polymerase chain reaction (RT-PCR) following MTM treatment.

After 24 h culturing in MTM, the viral loads were increased, represented by a 10-fold increase in detection sensitivity for H1N1, H9N2, and IBVs, a 100-fold increase for H3N2, and a 1,000-fold increase for H7N3. We further tested the effects of MTM on 19 IAV and 11 IBV stored clinical samples. The RT-PCR results showed that the positive detection rate of IAV samples increased from 63.16% (12/19) without MTM culturing to 78.95% (15/19) after 48 h culturing, and finally 89.47% (17/19) after 72 h culturing. MTM treatment of IBV clinical samples also increased the positive detection rate from 36.36% (4/11, 0 h) to 63.64% (7/11, 48 h) to 72.73% (8/11, 72 h). For clinical samples detected by RT-PCR, MTM outperformed other transport mediums in terms of viral detection rate (11.81% increase, P=0.007).

Our results demonstrated that the use of MTM for clinical applications can increase detection sensitivity, thus facilitating the accurate diagnosis of influenza infection.

## Linked entities

- **Diseases:** influenza (MONDO:0005812)

## Full-text entities

- **Diseases:** influenza infection (MESH:D007251)
- **Species:** H7N3 subtype (serotype) [taxon 119215], H9N2 subtype (serotype) [taxon 102796], Homo sapiens (human, species) [taxon 9606], H3N2 subtype (serotype) [taxon 119210], H1N1 subtype (serotype) [taxon 114727]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11254831/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11254831/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC11254831/full.md

---
Source: https://tomesphere.com/paper/PMC11254831